Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$IMMX

Immix Biopharma, Inc. Common Stock

XNAS

$13.11-0.61%$0.0800Prev $13.19LIVE Full chart Live alerts
No recent price bars, the chart lights up when IMMX starts printing.

Why is IMMX down today? It is at $13.11 (-0.61%), and our scanner flagged it 91 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IMMX spikes, and full due diligence on IMMX — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $IMMX alerts the moment volume spikes

Our scanner flagged $IMMX 91 times in the last 30 days. Create a free account to track $IMMX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$13.11
Change today
-0.61%
Previous close
$13.19
52-week range
$1.94 – $13.19
Valuation & dividend
Market cap
$845M
Ownership & volume
Shares outstanding
71.5M
SEC · as of 2026-08-03 · 17d
Insider ownership
24.7%
DEF 14A · 2026-04-06
Institutional own.
86.85%
Total held
100.0%
Short interest
9.5M
▲ +12% vs prior · as of 2026-07-31
Days to cover
5.2d
Avg daily volume
1.1M
Classification
Exchange
XNAS
Relative volumevs this time of day
5m
0.1x
15m
0.1x
1h
0.8x
1D
0.3x

Get free IMMX + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $IMMX down today?

8 alerts today18.1x RVOL

IMMX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 8 unusual-volume and momentum alerts on IMMX today, peaking at 18.1x its normal volume.

Likely catalystImmix Biopharma, Inc.: Q2 FY2026 results, three months to Dec 8, 2022, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedAug 14, 2026 · 6 days ago
Why is $IMMX moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile⚡ Ultra-low floatShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy6 analysts
Avg target $19.80(+51% upside)
Range $15 - $25
6 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

Insiders buying4 open-market buys7 buys, 0 sells last 3 months (11/0 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Buchan Jane
Director
Acquired (grant/award)+6Kadded 28%29Kn/aMay 22, 26
Hsu Jason
Director
Acquired (grant/award)+6Kadded 0.7%899Kn/aMay 22, 26
Chudnovsky Yekaterina
Director
Acquired (grant/award)+6Kn/a6Kn/aMay 22, 26
Ng Carey
Director
Acquired (grant/award)+6Kadded 31%26Kn/aMay 22, 26
Marquet Magda
Director
Acquired (grant/award)+6Kadded 14%52Kn/aMay 22, 26
Chang Nancy T
Director
Acquired (grant/award)+6Kadded 1.5%428Kn/aMay 22, 26
Adams Helen C.
Director
Acquired (grant/award)+6Kadded 3.6%181Kn/aMay 22, 26
Morris Gabriel S
Officer
Bought (open market)+770added 0.3%291K$5K
at $6.58
Dec 10, 25
Rachman Ilya M
Officer
Bought (open market)+746added <0.1%1.14M$5K
at $6.67
Dec 10, 25
Morris Gabriel S
Officer
Other156K
0.2% of company
added 53%451K$125K
at $0.800
Dec 8, 25
Rachman Ilya M
Officer
Bought (open market)+3Kadded 0.2%1.14M$5K
at $2.02
Sep 17, 25
Morris Gabriel S
Officer
Bought (open market)+3Kadded 0.9%291K$5K
at $1.97
Sep 16, 25

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

$IMMX is down 0.6% today and has an active shelf on file. See who may be selling into moves →

Dilution watch

Active shelf

At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $IMMX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$IMMX Sentiment

Bearish
Bearish31Bullish
📰 News: 1 bull · 4 bearToday: -0.6%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$IMMX Activity

News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

Alert· 19m ago
The Watcher BOUGHT $IMMX at $13.0400 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · swing","reason":"swing entry · breakout(13.03)","shares":5,"instance":"Rider","setup":"breakout(13.03)"}
at $13.04
Alert· 1h ago +2.9% vs EMA
IMMX 200EMA (5m) Trending · 55 bars · L3 · +2.88% above EMA · slope +0.74%
at $12.88
Alert· 1h ago
The Watcher SOLD $IMMX at $12.8300 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · swing","reason":"dead_tape","shares":3,"instance":"Rider"}
at $12.83
Alert· 2h ago
The Watcher BOUGHT $IMMX at $12.9900 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · swing","reason":"swing entry · breakout(13.00)","shares":3,"instance":"Rider","setup":"breakout(13.00)"}
at $12.99
Alert· 3h ago
The Watcher SOLD $IMMX at $12.9600 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · swing","reason":"dead_tape","shares":3,"instance":"Rider"}
at $12.96
Alert· 3h ago
The Watcher BOUGHT $IMMX at $13.1600 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · swing","reason":"swing entry · breakout(13.11)","shares":3,"instance":"Rider","setup":"breakout(13.11)"}
at $13.16
Alert· 4h ago
The Watcher SOLD $IMMX at $12.9200 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · swing","reason":"dead_tape","shares":2,"instance":"Rider"}
at $12.92
Alert· 4h ago
The Watcher BOUGHT $IMMX at $13.0900 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · swing","reason":"swing entry · breakout(13.04)","shares":2,"instance":"Rider","setup":"breakout(13.04)"}
at $13.09
Alert· 5h ago 18.1× RVOL
IMMX hit 18.119x RVOL at 9:52 AM ET
at $12.79
Alert· 22h ago +2.8% vs EMA
IMMX 50EMA (5m) Trending · 74 bars · L3 · +2.81% above EMA · slope +1.45%
at $13.15
Alert· 23h ago +3.3% vs EMA
IMMX 200EMA (1m) Trending · 254 bars · L5 · +3.29% above EMA · slope +0.43%
at $13.15
Alert· 1d ago +1.7% vs EMA
$IMMX near 200 EMA: +1.66% from 200 EMA at 2:35 PM ET
at $12.86
Alert· 1d ago +1.09%
$IMMX moved +1.09% in 1 min (Level 1) at 2:35 PM ET
at $12.86
Alert· 1d ago 8.0× RVOL
IMMX hit 7.989x RVOL at 2:35 PM ET
at $12.85
Alert· 1d ago +2.54%
$IMMX moved +2.54% (~15m high-low range 2.54%) (Level 2) at 12:33 PM ET
at $12.73
Alert· 1d ago 2.5× RVOL
IMMX hit 2.473x RVOL at 12:33 PM ET
at $12.73
Alert· 1d ago 9.2× RVOL
IMMX hit 9.233x RVOL at 10:08 AM ET
at $12.85
Alert· 2d ago -0.2% vs EMA
$IMMX near 200 EMA: -0.18% from 200 EMA at 2:47 PM ET
at $11.52
Alert· 2d ago 3.3× RVOL
IMMX hit 3.324x RVOL at 2:47 PM ET
at $11.52
Alert· 2d ago +0.5% vs EMA
$IMMX near 200 EMA: +0.49% from 200 EMA at 1:57 PM ET
at $11.59
Alert· 2d ago 3.8× RVOL
IMMX hit 3.764x RVOL at 1:57 PM ET
at $11.59
Alert· 2d ago +2.7% vs EMA
$IMMX near 200 EMA: +2.74% from 200 EMA at 1:11 PM ET
at $11.79
Alert· 2d ago +1.51%
$IMMX moved +1.51% in 1 min (Level 1) at 1:11 PM ET
at $11.80
Alert· 2d ago 5.1× RVOL
IMMX hit 5.121x RVOL at 1:11 PM ET
at $11.79
Alert· 2d ago 3.4× RVOL
IMMX hit 3.421x RVOL at 11:33 AM ET
at $11.58
News· SEC EDGAR· 12d ago
Immix Biopharma, Inc.: Q2 FY2026 results, three months to Dec 8, 2022
News· GlobeNewswire Inc.· 15d ago Bearish
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX
News· GlobeNewswire Inc.· 27d ago Bearish
EQPT LAWSUIT: EquipmentShare.com Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton To Learn How They Might Recover Their Losses
News· GlobeNewswire Inc.· 30d ago Bearish
Immix Biopharma Investigated by the Portnoy Law Firm
News· GlobeNewswire Inc.· 31d ago Bearish
IMMX ALERT: Immix Biopharma Investigated for Securities Fraud Violations by Block & Leviton; Investors Should Contact the Firm
News· SEC EDGAR· 31d ago
Immix Biopharma, Inc. filed an 8-K: Other Material Event
News· SEC EDGAR· 82d ago
Immix Biopharma, Inc. filed an 8-K: Shareholder Vote
News· GlobeNewswire Inc.· 89d ago Bullish
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

IMMX stock FAQ

Why is $IMMX down today?

IMMX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 8 unusual-volume and momentum alerts on IMMX today, peaking at 18.1x its normal volume.

What is the IMMX stock price today?

IMMX last traded at $13.11, down 0.61% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live IMMX alerts?

The IMMX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMMX 91 times in the last 30 days.

What exchange is IMMX on?

IMMX (Immix Biopharma, Inc. Common Stock) trades on XNAS, with a market cap of about $845M.

Is IMMX good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMMX for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.